GlobalData on MSN4d
Bavarian Nordic’s mpox vaccine to be trialled in pregnant women and infants
Pregnant women and infants are at risk should they contract mpox but there are no approved vaccines for this population.
GlobalData on MSN13d
Bavarian eyes Mpox vaccine label expansion to include toddlers, kickstarts Phase II trial
The registrational trial is expected to support the Bavarian’s mpox/smallpox vaccine use in children between 2 and 11 years ...
manilatimes13d
First Children Vaccinated in New Clinical Study Seeking to Expand the Indication for Bavarian Nordic's Mpox Vaccine
Results from this study could support an extension of the current approval of MVA-BN to include children from 2 years of age ...
Finanznachrichten13d
Bavarian Nordic A/S: First Children Vaccinated in New Clinical Study Seeking to Expand the Indication for Bavarian Nordic's Mpox Vaccine
COPENHAGEN, Denmark, October 29, 2024 - Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of a clinical study of the MVA-BN ® mpox/smallpox vaccine in children 2 to 11 years of age.
Mena FN13d
First Children Vaccinated In New Clinical Study Seeking To Expand The Indication For Bavarian Nordic’S Mpox Vaccine
COPENHAGEN, Denmark, October 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of a clinical study of the MVA-BN® mpox/smallpox vaccine in children 2 to 11 years of age.
What is mpox? Symptoms, transmission and vaccines
The WHO has declared a global health emergency over a new strain of mpox rapidly spreading in Africa. Here’s what you need to ...
clinicaltrialsarena4d
Bavarian Nordic’s mpox vaccine to be trialled in pregnant women and infants
Bavarian Nordic’s vaccine is already approved for the prevention of mpox and smallpox in adults aged 18 and over. It has received emergency approval in Europe for teenagers. Image credit: Shutterstock ...